Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ALK201Phase 22 trials
Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer), Advanced Cancer, Advanced Solid Tumors
- Ametinib MesylatePhase 22 trials
Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors, Non-small Cell Lung Cancer (NSCLC)
- and oxaliplatinPhase 22 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
- AST-3424Phase 22 trials
Zhejiang Hisun Pharmaceutical Co. Ltd. · HCC - Hepatocellular Carcinoma, Advanced Solid Tumors, Hepatocellular Carcinoma
- Autologous Tumor Infiltrating LymphocytesGC101 TILPhase 22 trials
Shanghai Juncell Therapeutics · Non Small Cell Lung Cancer, Melanoma
- AVZO-021Phase 22 trials
Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumor
- AZD0171MSC-1Phase 22 trials
AstraZeneca · Non-small Cell Lung Cancer, Locally Advanced or Metastatic Solid Tumours
- AZD2287Imaging agentPhase 22 trials
AstraZeneca · Metastatic Prostate Cancer
- AZD3470Phase 22 trials
AstraZeneca · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
- AzeliragonPhase 22 trials
Cantex Pharmaceuticals · Glioblastoma
- B1962Phase 22 trials
Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers
- B7-H3 CAR-NKEB-G3B7-NK dual-target CAR-NK cells, Dual-target GPC3Phase 22 trials
Beijing Biotech · Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer, Relapsed Neuroblastoma
- BelvarafenibHM95573Phase 22 trials
Hanmi Pharmaceutical Company Limited · Advanced or Metastatic Melanoma, Solid Tumors
- BEY1107Phase 22 trials
BeyondBio Inc. · Metastatic Colorectal Cancer, Locally Advanced or Metastatic Pancreatic Cancer
- BL-M09D1Phase 22 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gynecological Malignancies, Urothelial Carcinoma (UC)
- BLEX 404Phase 22 trials
Rgene Corporation · Pancreatic Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung
- BLEX 404 LiquidPhase 22 trials
BioLite, Inc. · Myelodysplastic Syndrome (MDS), Triple Negative Breast Cancer
- BNT326Phase 22 trials
BioNTech SE · Advanced Solid Tumor, Non-small Cell Lung Cancer
- BreakVaxPhase 22 trials
BreakBio Corp · Triple-Negative Breast Cancer (TNBC), Glioblastoma (GBM)
- BRIMOCHOL PF eye dropsCARBACHOL PF eye drops, Brimonidine tartrate eye dropsPhase 22 trials
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Presbyopia, Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
- BT7480Phase 22 trials
BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor
- CAB-AXL-ADCBA3011Phase 22 trials
BioAtla, Inc. · Non-Small-Cell Lung Cancer, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma
- CamonsertibRP-3500Phase 22 trials
Roche (Genentech) · Solid Tumors, Advanced Solid Tumor
- Carboplatin AUC-5Phase 22 trials
Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer
- Checkpoint InhibitorPhase 22 trials
EpicentRx, Inc. · Solid Tumor, Adult, Cancer, Neoplasms
- COH04S1GEO-CM04S1, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1Phase 22 trials
GeoVax, Inc. · COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia
- CVL006Phase 22 trials
Convalife (Shanghai) Co., Ltd. · Advanced Solid Tumor
- CVL237Phase 22 trials
Convalife (Shanghai) Co., Ltd. · Advanced Solid Tumors, Locally Advanced or Metastatic Solid Tumors, PTEN Loss or Low Expression
- CVM-1118TRX-818Phase 22 trials
TaiRx, Inc. · Hepatocellular Carcinoma, Advanced Cancer, Neuroendocrine Tumors
- CYH33Phase 22 trials
Haihe Biopharma Co., Ltd. · PIK3CA-Related Overgrowth Spectrum (PROS), PIK3CA-related Vascular Malformations (PRVM), Ovarian Cancer
- D3S-001Phase 22 trials
D3 Bio (Wuxi) Co., Ltd · Advanced Solid Tumors With MAPK Pathway Mutations, KRAS P.G12C
- DanburstotugIMC-001Phase 22 trials
ImmuneOncia Therapeutics Inc. · TMB-H, Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors, Extranodal NK/T-cell Lymphoma, Nasal Type
- DB-1305BNT325Phase 22 trials
DualityBio Inc. · Solid Tumors, Advanced Solid Tumor
- DenikitugGS-1811, DENPhase 22 trials
Gilead Sciences · Advanced Microsatellite Stable Colorectal Cancer, HER2-negative, Gastroesophageal Junction
- DNA VaccinePhase 22 trials
NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)
- DOC1021Phase 22 trials
Diakonos Oncology Corporation · Glioblastoma (GBM), Refractory Melanoma
- Dositinib mesylatePhase 22 trials
Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer
- DS-3939aPhase 22 trials
Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
- DS-8201Phase 22 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Breast Cancer, Advanced Solid Tumor
- DS010Phase 22 trials
Dartsbio Pharmaceuticals Ltd. · Cancer, Cachexia
- DSP107Phase 22 trials
Kahr Bio Australia Pty Ltd · Colorectal Cancer, Advanced Solid Tumor, Non Small Cell Lung Cancer
- Dual-target CAR-NK cell productPhase 22 trials
Beijing Biotech · Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma
- DZD6008Phase 22 trials
Dizal Pharmaceuticals · Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer
- EB-DART-NK01DLL3, CD56 CAR-NK cellsPhase 22 trials
Beijing Biotech · Small Cell Lung Cancer (SCLC), Relapsed/Refractory SCLC, Extensive-stage SCLC
- EB-DNK101 dual-targeting CAR-NK cellsMSLN + MUC1Phase 22 trials
Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced
- EB-DNK102 dual-targeting CAR-NK cellsCLDN18.2 + MUC1Phase 22 trials
Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced
- EB-DUO-CAR-NK-CEAGCCPhase 22 trials
Beijing Biotech · Colorectal Cancer Metastatic, Adenocarcinoma of Colon, Colorectal Cancer
- endoxifenPhase 22 trials
Atossa Therapeutics, Inc. · Precocious Puberty, Gonadotropin-dependent, Breast Neoplasms, Invasive Breast Cancer
- ERAS-007Phase 22 trials
Erasca, Inc. · Advanced or Metastatic Solid Tumors, Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma
- FG-B901Phase 22 trials
FutureGen Biopharmaceutical (Beijing) Co., Ltd · Claudin 18.2, Solid Tumor Malignancies, Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.